T-cell type acute lymphoblastic leukemia following cyclosporin a therapy for aplastic anemia

International Journal of Hematology

Volumn 73, Issue 2, 2001, Pages 226-229

  Hirose, Yuko ^a   Masaki, Yasufumi ^a   Ebata, Kazumi ^a   Okada, Jun ^a   Kim, Chang gi ^a   Ogawa, Noriyoshi ^a   Wano, Yuji ^a   Sugai, Susumu ^a  

^a KANAZAWA MEDICAL UNIVERSITY   (Japan)

Author keywords

Aplastic anemia; Cyclosporin A; T ALL

Indexed keywords

CYCLOSPORIN; LYMPHOCYTE ANTIGEN RECEPTOR;

ACUTE LYMPHOCYTIC LEUKEMIA; ADOLESCENT; APLASTIC ANEMIA; ARTICLE; CASE REPORT; CELL CLONE; CELL TRANSFORMATION; CHEMICALLY INDUCED DISORDER; DRUG EFFECT; GENE REARRANGEMENT; GENETICS; HUMAN; IMMUNOPHENOTYPING; MALE; PATHOLOGY; T CELL LEUKEMIA;

ADOLESCENT; ANEMIA, APLASTIC; CELL TRANSFORMATION, NEOPLASTIC; CLONE CELLS; CYCLOSPORINE; GENE REARRANGEMENT; HUMANS; IMMUNOPHENOTYPING; LEUKEMIA, LYMPHOCYTIC, ACUTE; LEUKEMIA, T-CELL; MALE; RECEPTORS, ANTIGEN, T-CELL;

EID: 0035260962     PISSN: 09255710     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF02981942     Document Type: Article

References (1)

1. Hojo M, Morimoto T, Maluccio M, et al. Cyclosporine induces cancer progression by a cell-autonomous mechanism. Nature. 1999; 397:530-534.